Inhaled insulin linked to lung cancer: Pfizer
Clinical trials of the inhaled insulin product Exubera revealed an increase in the number of lung cancer patient, leading Nektar Therapeutics to end talks with potential partners to market the product, Pfizer Inc and…
1 min read